Alexander D. Fine
About
Alexander D. Fine is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Alexander D. Fine has authored 23 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 9 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alexander D. Fine's work include Cancer Genomics and Diagnostics (15 papers), Genetic factors in colorectal cancer (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Alexander D. Fine is often cited by papers focused on Cancer Genomics and Diagnostics (15 papers), Genetic factors in colorectal cancer (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Alexander D. Fine collaborates with scholars based in United States, Switzerland and Italy. Alexander D. Fine's co-authors include Geoffrey R. Oxnard, Russell W. Madison, Gerald Li, Ryon P. Graf, Todd M. Morgan, Zachery R. Reichert, Tamara Snow, Emily Castellanos, Daniel G. Stover and Filippo Gustavo Dall’Olio and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Cancer Research.
In The Last Decade
Alexander D. Fine
22 papers receiving 349 citations
Peers
Alexander D. Fine
Emanuela Minna Italy
Laia Perez‐Roca Spain
Jian Carrot‐Zhang United States
Marie Klintman Sweden
Junhao Mu China
Shuliang Zhao China
Gavin Harris New Zealand
Xiaoding Liu China
Tomasz Tyszkiewicz Poland
Miao Lu China
Citations per year, relative to Alexander D. Fine Alexander D. Fine (= 1×)
peers
Emanuela Minna
Countries citing papers authored by Alexander D. Fine
Since
Specialization
Citations
This map shows the geographic impact of Alexander D. Fine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander D. Fine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander D. Fine more than expected).
Fields of papers citing papers by Alexander D. Fine
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Alexander D. Fine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander D. Fine. The network helps show where Alexander D. Fine may publish in the future.
Co-authorship network of co-authors of Alexander D. Fine
This figure shows the co-authorship network connecting the top 25 collaborators of Alexander D. Fine. A scholar is included among the top collaborators of Alexander D. Fine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander D. Fine. Alexander D. Fine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Madison, Russell W., Zoe J. Assaf, Alexander D. Fine, et al.. (2025). Real-World Validity of Tissue-Agnostic Circulating Tumor DNA Response Monitoring in Lung Cancers Treated With Chemotherapy, Immunotherapy, or Targeted Agents. JTO Clinical and Research Reports. 6(9). 100829–100829.
2.
Antonarakis, Emmanuel S., Catherine H. Marshall, Derek W. Brown, et al.. (2025). Equal-depth sequencing of white blood cells (WBC) and plasma from prostate cancer (PCa) liquid biopsies (LBx) and association with clonal hematopoiesis (CH) confounders in clinically relevant genes.. Journal of Clinical Oncology. 43(5_suppl). 221–221.
3.
Brown, Derek W., Hanna Tukachinsky, Jason D. Hughes, et al.. (2025). Evaluation of a variant origin prediction (VOP) algorithm to distinguish clonal hematopoiesis (CH) variants from tumor-derived variants and to predict metastatic castrate resistant prostate cancer (mCRPC) clinical responses.. Journal of Clinical Oncology. 43(5_suppl). 201–201.
4.
Madison, Russell W., Yanmei Huang, Alexander D. Fine, et al.. (2024). Abstract 971: Validation of a tumor-naïve circulating tumor DNA (ctDNA) response monitoring panel in advanced non-small cell lung cancer (aNSCLC). Cancer Research. 84(6_Supplement). 971–971.
5.
Tyler, Anna L., Romy Kursawe, Annat Haber, et al.. (2023). Variation in histone configurations correlates with gene expression across nine inbred strains of mice. Genome Research. 33(6). 857–871.
6.
Loree, Jonathan M., Russell W. Madison, Christopher J. O’Callaghan, et al.. (2023). Feasibility of circulating tumor DNA (ctDNA) to guide organ preservation in patients with node-negative rectal cancer undergoing neoadjuvant chemotherapy, excision, and observation in the phase II CCTG CO.28 trial.. Journal of Clinical Oncology. 41(4_suppl). 180–180.
7.
Assaf, Zoe J., Wei Zou, Alexander D. Fine, et al.. (2023). A longitudinal circulating tumor DNA-based model associated with survival in metastatic non-small-cell lung cancer. Nature Medicine. 29(4). 859–868.
8.
Sweeney, Christopher, Chang Xu, Jie He, et al.. (2023). Abstract 3362: Evaluation of circulating tumor DNA kinetics as a prognostic biomarker for overall survival in metastatic castrate resistant prostate cancer using a novel methylation sequencing research assay. Cancer Research. 83(7_Supplement). 3362–3362.
9.
Schwartzberg, Lee S., Gerald Li, Khaled Tolba, et al.. (2022). Complementary Roles for Tissue- and Blood-Based Comprehensive Genomic Profiling for Detection of Actionable Driver Alterations in Advanced NSCLC. JTO Clinical and Research Reports. 3(9). 100386–100386.
10.
Lin, Douglas I., Alexander D. Fine, Natalie Danziger, et al.. (2022). Molecular analysis of endometrial serous carcinoma reveals distinct clinicopathologic and genomic subgroups. Gynecologic Oncology. 164(3). 558–565.
11.
Reichert, Zachery R., Todd M. Morgan, Gerald Li, et al.. (2022). Prognostic value of plasma circulating tumor DNA fraction across four common cancer types: a real-world outcomes study. Annals of Oncology. 34(1). 111–120.
12.
Sokol, Ethan S., Dexter X. Jin, Alexander D. Fine, et al.. (2022). PARP Inhibitor Insensitivity to BRCA1/2 Monoallelic Mutations in Microsatellite Instability-High Cancers. JCO Precision Oncology. 6(6). e2100531–e2100531.
13.
Young, Amanda, Halla Nimeiri, Russell W. Madison, et al.. (2022). Molecular residual disease (MRD) detection with a tissue comprehensive genomic profiling (CGP)-informed personalized monitoring assay: An exploratory analysis of the IMvigor-010 observation arm.. Journal of Clinical Oncology. 40(6_suppl). 448–448.
14.
Lonardi, Sara, Halla Nimeiri, Chang Xu, et al.. (2022). Comprehensive Genomic Profiling (CGP)-Informed Personalized Molecular Residual Disease (MRD) Detection: An Exploratory Analysis from the PREDATOR Study of Metastatic Colorectal Cancer (mCRC) Patients Undergoing Surgical Resection. International Journal of Molecular Sciences. 23(19). 11529–11529.
15.
Nimeiri, Halla, Amanda Young, Russell W. Madison, et al.. (2022). Comprehensive genomic profiling (CGP)-informed personalized molecular residual disease (MRD) detection: An exploratory analysis from the PREDATOR study of metastatic colorectal cancer (mCRC) patients undergoing surgical resection.. Journal of Clinical Oncology. 40(4_suppl). 187–187.
16.
Assaf, Zoe J., Alexander D. Fine, Wei Zou, et al.. (2021). MA07.02 Evaluating Circulating Tumor DNA to Predict Overall Survival Risk in Non-Squamous Non-Small Cell Lung Cancer in IMpower150. Journal of Thoracic Oncology. 16(10). S905–S906.
17.
Vanderwalde, Ari M., Mong‐Liang Lu, Sophia L. Maund, et al.. (2021). P10.14 ctDNA and Real-World Response (rwR) in Patients With Lung Cancer From A Prospective Real-World Clinico-Genomic (PCG) Study. Journal of Thoracic Oncology. 16(10). S1005–S1005.
18.
Preuß, Christoph, Ravi S. Pandey, Erin Piazza, et al.. (2020). A novel systems biology approach to evaluate mouse models of late-onset Alzheimer’s disease. Molecular Neurodegeneration. 15(1). 67–67.
19.
Bhattacharyya, Tanmoy, Michael Walker, Natalie R. Powers, et al.. (2019). Prdm9 and Meiotic Cohesin Proteins Cooperatively Promote DNA Double-Strand Break Formation in Mammalian Spermatocytes. Current Biology. 29(6). 1002–1018.e7.
20.
Fine, Alexander D., Robyn L. Ball, Yasuhiro Fujiwara, Mary Ann Handel, & Gregory W. Carter. (2019). Uncoupling of transcriptomic and cytological differentiation in mouse spermatocytes with impaired meiosis. Molecular Biology of the Cell. 30(5). 717–728.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Emanuela Minna Breakdown of academic impact, for papers by Laia Perez‐Roca Breakdown of academic impact, for papers by Jian Carrot‐Zhang Breakdown of academic impact, for papers by Marie Klintman Breakdown of academic impact, for papers by Junhao Mu Breakdown of academic impact, for papers by Shuliang Zhao Breakdown of academic impact, for papers by Gavin Harris Breakdown of academic impact, for papers by Xiaoding Liu Breakdown of academic impact, for papers by Tomasz Tyszkiewicz Breakdown of academic impact, for papers by Miao Lu